If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Ezia Bello is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
trabectedin Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Myxoid Liposarcoma Medicine & Life Sciences
Juvenile Myelomonocytic Leukemia Medicine & Life Sciences
Heterografts Medicine & Life Sciences
Leukemia, Myelomonocytic, Chronic Medicine & Life Sciences
Tumor Microenvironment Medicine & Life Sciences
eribulin Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2017 2019

Combination of PPARg agonist pioglitazone and trabectedin induce adipocyte differentiation to overcome trabectedin resistance in myxoid liposarcomas

Frapolli, R., Bello, E., Ponzo, M., Craparotta, I., Mannarino, L., Ballabio, S., Marchini, S., Carrassa, L., Ubezio, P., Porcu, L., Brich, S., Sanfilippo, R., Casali, P. G., Gronchi, A., Pilotti, S. & D'Incalci, M., Dec 15 2019, In : Clinical Cancer Research. 25, 24, p. 7565-7575 11 p.

Research output: Contribution to journalArticle

trabectedin
pioglitazone
Myxoid Liposarcoma
Adipocytes
Adipogenesis

Combination of PPARg agonist pioglitazone and trabectedin induce adipocyte differentiation to overcome trabectedin resistance in myxoid liposarcomas

Frapolli, R., Bello, E., Ponzo, M., Craparotta, I., Mannarino, L., Ballabio, S., Marchini, S., Carrassa, L., Ubezio, P., Porcu, L., Brich, S., Sanfilippo, R., Casali, P. G., Gronchi, A., Pilotti, S. & D'Incalci, M., Dec 15 2019, In : Clin. Cancer Res.. 25, 24, p. 7565-7575 11 p.

Research output: Contribution to journalArticle

Establishment and characterisation of a new patient-derived model of myxoid liposarcoma with acquired resistance to trabectedin

Bello, E., Brich, S., Craparotta, I., Mannarino, L., Ballabio, S., Gatta, R., Marchini, S., Carrassa, L., Matteo, C., Sanfilippo, R., Gronchi, A., Casali, P. G., Pilotti, S., D’Incalci, M. & Frapolli, R., Sep 10 2019, In : British Journal of Cancer. 121, 6, p. 464-473 10 p.

Research output: Contribution to journalArticle

trabectedin
Myxoid Liposarcoma
Heterografts
Nude Mice
Therapeutics

Establishment and characterisation of a new patient-derived model of myxoid liposarcoma with acquired resistance to trabectedin

Bello, E., Brich, S., Craparotta, I., Mannarino, L., Ballabio, S., Gatta, R., Marchini, S., Carrassa, L., Matteo, C., Sanfilippo, R., Gronchi, A., Casali, P. G., Pilotti, S., D’Incalci, M. & Frapolli, R., Sep 10 2019, In : British Journal of Cancer. 121, 6, p. 464-473 10 p.

Research output: Contribution to journalArticle

Readily prepared biodegradable nanoparticles to formulate poorly water soluble drugs improving their pharmacological properties: The example of trabectedin

Capasso Palmiero, U., Morosi, L., Bello, E., Ponzo, M., Frapolli, R., Matteo, C., Ferrari, M., Zucchetti, M., Minoli, L., De Maglie, M., Romanelli, P., Morbidelli, M., D'Incalci, M. & Moscatelli, D., Apr 28 2018, In : Journal of Controlled Release. 276, p. 140-149 10 p.

Research output: Contribution to journalArticle

trabectedin
Nanoparticles
Pharmacology
Water
Pharmaceutical Preparations